Home » Topics » Disease categories and therapies » Ear, nose and throat

Ear, nose and throat
RSS

Novartis discloses protein atonal homolog 1 activators

Oct. 18, 2018

Insm1 keeps hair cells in 'n' out

Oct. 17, 2018

European clearance for phase II study of SENS-401 for sudden sensorineuronal hearing loss

Aug. 20, 2018

Discovery of a novel enzymatic function of histone deacetylase 11

Aug. 14, 2018

First patients dosed in phase I/II study of FX-322

Aug. 8, 2018

Otonomy initiates additional phase III trial of Otividex for Meniere's disease

July 27, 2018

New phase IIa study aims to confirm absence of anticholinergic effects with seliforant

July 25, 2018

Addition of sodium thiosulfate to cisplatin lowers incidence of cisplatin-induced hearing loss

July 24, 2018

Hearing light, no synesthesia required

July 18, 2018

KCNC1/KCNC2 channel modulators presented by Autifony Therapeutics

July 10, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...